AAAAAA

   
Results: 1-17 |
Results: 17
PRODUCTION OF DNA STRAND BREAKS BY N-NITROSODIMETHYLAMINE AND 2-AMINO-3-METHYLIMIDAZO[4,5-F]QUINOLINE IN THLE CELLS EXPRESSING HUMAN CYP ISOENZYMES AND INHIBITION BY SULFORAPHANE
Authors: BARCELO S MACE K PFEIFER AMA CHIPMAN JK
Citation: S. Barcelo et al., PRODUCTION OF DNA STRAND BREAKS BY N-NITROSODIMETHYLAMINE AND 2-AMINO-3-METHYLIMIDAZO[4,5-F]QUINOLINE IN THLE CELLS EXPRESSING HUMAN CYP ISOENZYMES AND INHIBITION BY SULFORAPHANE, Mutation research. Fundamental and molecular mechanisms of mutagenesis, 402(1-2), 1998, pp. 111-120
CHARACTERIZATION OF XENOBIOTIC-METABOLIZING ENZYME EXPRESSION IN HUMAN BRONCHIAL-MUCOSA AND PERIPHERAL LUNG TISSUES
Authors: MACE K BOWMAN ED VAUTRAVERS P SHIELDS PG HARRIS CC PFEIFER AMA
Citation: K. Mace et al., CHARACTERIZATION OF XENOBIOTIC-METABOLIZING ENZYME EXPRESSION IN HUMAN BRONCHIAL-MUCOSA AND PERIPHERAL LUNG TISSUES, European journal of cancer, 34(6), 1998, pp. 914-920
IDENTIFICATION OF HUMAN AND RABBIT CYTOCHROMES P450 1A2 AS MAJOR ISOFORMS INVOLVED IN THIABENDAZOLE 5-HYDROXYLATION
Authors: COULET M DACASTO M EECKHOUTTE C LARRIEU G SUTRA JF ALVINERIE M MACE K PFEIFER AMA GALTIER P
Citation: M. Coulet et al., IDENTIFICATION OF HUMAN AND RABBIT CYTOCHROMES P450 1A2 AS MAJOR ISOFORMS INVOLVED IN THIABENDAZOLE 5-HYDROXYLATION, Fundamental and clinical pharmacology, 12(2), 1998, pp. 225-235
EXPRESSION OF CYTOCHROME-P450 3A5, 2C18, 2E1 AND 1A1 IN NORMAL AND IMMORTALIZED HUMAN KERATINOCYTES
Authors: BAUER M HERTZEISEN A MACE K MALNOE A PFEIFER AMA
Citation: M. Bauer et al., EXPRESSION OF CYTOCHROME-P450 3A5, 2C18, 2E1 AND 1A1 IN NORMAL AND IMMORTALIZED HUMAN KERATINOCYTES, Journal of investigative dermatology, 110(4), 1998, pp. 565-565
PHARMACODYNAMICS OF REOPRO (C7E3 FAB) - FREE PLASMA-LEVELS DETERMINE CLINICAL EFFICACY
Authors: WAGNER C MACE K MASCELLI MA DERITA R LANCE E WEISMAN H GHRAYEB J JORDAN R
Citation: C. Wagner et al., PHARMACODYNAMICS OF REOPRO (C7E3 FAB) - FREE PLASMA-LEVELS DETERMINE CLINICAL EFFICACY, Thrombosis and haemostasis, 1997, pp. 26-26
MECHANISMS INVOLVED IN THE CHEMOPROTECTIVE EFFECTS OF ROSEMARY EXTRACT STUDIED IN HUMAN LIVER AND BRONCHIAL CELLS
Authors: OFFORD EA MACE K AVANTI O PFEIFER AMA
Citation: Ea. Offord et al., MECHANISMS INVOLVED IN THE CHEMOPROTECTIVE EFFECTS OF ROSEMARY EXTRACT STUDIED IN HUMAN LIVER AND BRONCHIAL CELLS, Cancer letters, 114(1-2), 1997, pp. 275-281
METABOLISM-COMPETENT HUMAN EPITHELIAL MODELS FOR TOXICOLOGICAL STUDIES
Authors: MACE K MAUTHE RJ BLUM S TURTELTAUB KW PFEIFER AMA
Citation: K. Mace et al., METABOLISM-COMPETENT HUMAN EPITHELIAL MODELS FOR TOXICOLOGICAL STUDIES, European journal of cell biology, 74, 1997, pp. 103-103
AFLATOXIN B-1-INDUCED DNA ADDUCT FORMATION AND P53 MUTATIONS IN CYP450-EXPRESSING HUMAN LIVER-CELL LINES
Authors: MACE K AGUILAR F WANG JS VAUTRAVERS P GOMEZLECHON M GONZALEZ FJ GROOPMAN J HARRIS CC PFEIFER AMA
Citation: K. Mace et al., AFLATOXIN B-1-INDUCED DNA ADDUCT FORMATION AND P53 MUTATIONS IN CYP450-EXPRESSING HUMAN LIVER-CELL LINES, Carcinogenesis, 18(7), 1997, pp. 1291-1297
IMMORTALIZED HUMAN KERATINOCYTES WITH A NORMALIZED DIFFERENTIATION PATTERN AS A MODEL TO STUDY THE METABOLISM OF XENOBIOTICS AND ESSENTIAL FATTY-ACIDS (EFA)
Authors: BAUR M TROMVOUKIS Y MALNOE A CHARBONNET C MACE K OFFORD EA PFEIFER AMA
Citation: M. Baur et al., IMMORTALIZED HUMAN KERATINOCYTES WITH A NORMALIZED DIFFERENTIATION PATTERN AS A MODEL TO STUDY THE METABOLISM OF XENOBIOTICS AND ESSENTIAL FATTY-ACIDS (EFA), Journal of investigative dermatology, 108(4), 1997, pp. 801-801
REDUCTION IN SERUM VEGF AND SICAM-1 ARE ASSOCIATED WITH CLINICAL-RESPONSE TO ANTI-TNF THERAPY IN PATIENTS WITH SEVERE CROHNS-DISEASE
Authors: SHEALY D MACE K DEWOODY K LEONE A DERITA R GHRAYEB J
Citation: D. Shealy et al., REDUCTION IN SERUM VEGF AND SICAM-1 ARE ASSOCIATED WITH CLINICAL-RESPONSE TO ANTI-TNF THERAPY IN PATIENTS WITH SEVERE CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 1090-1090
ROSEMARY COMPONENTS INHIBIT BENZO[ALPHA]PYRENE-INDUCED GENOTOXICITY IN HUMAN BRONCHIAL CELLS
Authors: OFFORD EA MACE K RUFFIEUX C MALNOE A PFEIFER AMA
Citation: Ea. Offord et al., ROSEMARY COMPONENTS INHIBIT BENZO[ALPHA]PYRENE-INDUCED GENOTOXICITY IN HUMAN BRONCHIAL CELLS, Carcinogenesis, 16(9), 1995, pp. 2057-2062
NITRIC-OXIDE AND ETHYLNITROSOUREA - RELATIVE MUTAGENICITY IN THE P53 TUMOR-SUPPRESSOR AND HYPOXANTHINE-PHOSPHORIBOSYLTRANSFERASE GENES
Authors: FELLEYBOSCO E MIRKOVITCH J AMBS S MACE K PFEIFER A KEEFER LK HARRIS CC
Citation: E. Felleybosco et al., NITRIC-OXIDE AND ETHYLNITROSOUREA - RELATIVE MUTAGENICITY IN THE P53 TUMOR-SUPPRESSOR AND HYPOXANTHINE-PHOSPHORIBOSYLTRANSFERASE GENES, Carcinogenesis, 16(9), 1995, pp. 2069-2074
CYTOCHROME-P-450 ISOFORMS IMPLICATED IN OCHRATOXIN A GENOTOXICITY DETERMINED BY DNA ADDUCT FORMATION
Authors: GROSSE Y CASTEGNARO M MACE K BARTSCH H MOHR U DIRHEIMER G PINELLI E PFEIFER A PFOHLLESZKOWICZ A
Citation: Y. Grosse et al., CYTOCHROME-P-450 ISOFORMS IMPLICATED IN OCHRATOXIN A GENOTOXICITY DETERMINED BY DNA ADDUCT FORMATION, Clinical chemistry, 41(12B), 1995, pp. 1927-1929
CONSTITUTIVE AND INDUCIBLE EXPRESSION OF DRUG-METABOLIZING-ENZYMES INCULTURED HUMAN KERATINOCYTES
Authors: VECCHINI F MACE K MAGDALOU J MAHE Y BERNARD BA SHROOT B
Citation: F. Vecchini et al., CONSTITUTIVE AND INDUCIBLE EXPRESSION OF DRUG-METABOLIZING-ENZYMES INCULTURED HUMAN KERATINOCYTES, British journal of dermatology, 132(1), 1995, pp. 14-21
RECRUITMENT OF PREEXISTING ANTI-FAB IMMUNOGLOBULINS TO PLATELETS DOESNOT AFFECT THE SAFETY, PHARMACOKINETICS OR PHARMACODYNAMICS OF REOPRO(TM)
Authors: LANCE E JORDAN B PRESTON A MACE K SCHAIBLE T MASCELLI MA
Citation: E. Lance et al., RECRUITMENT OF PREEXISTING ANTI-FAB IMMUNOGLOBULINS TO PLATELETS DOESNOT AFFECT THE SAFETY, PHARMACOKINETICS OR PHARMACODYNAMICS OF REOPRO(TM), Blood, 86(10), 1995, pp. 3594-3594
PLASMA PHARMACOKINETICS AND BIOLOGICAL-ACTIVITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY, F105, IN CYNOMOLGUS MONKEYS
Authors: CAVACINI LA POWER J EMES CL MACE K TREACY G POSNER MR
Citation: La. Cavacini et al., PLASMA PHARMACOKINETICS AND BIOLOGICAL-ACTIVITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY, F105, IN CYNOMOLGUS MONKEYS, Journal of immunotherapy with emphasis on tumor immunology, 15(4), 1994, pp. 251-256
ACTIVATION OF PROMUTAGENS IN A HUMAN BRONCHIAL EPITHELIAL-CELL LINE STABLY EXPRESSING HUMAN CYTOCHROME-P450 1A2
Authors: MACE K GONZALEZ FJ MCCONNELL IR GARNER RC AVANTI O HARRIS CC PFEIFER AMA
Citation: K. Mace et al., ACTIVATION OF PROMUTAGENS IN A HUMAN BRONCHIAL EPITHELIAL-CELL LINE STABLY EXPRESSING HUMAN CYTOCHROME-P450 1A2, Molecular carcinogenesis, 11(2), 1994, pp. 65-73
Risultati: 1-17 |